Publications by authors named "Lars Franzen"

Claim this Profile
U
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.
Per Fransson, Per Nilsson, Adalsteinn Gunnlaugsson, Lars Beckman, Björn Tavelin

Lancet Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum re "Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer-Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial" [Eur Urol 2019;76:823-30].
Pirkko-Liisa Kellokumpu-Lehtinen, Marie Hjälm-Eriksson, Camilla Thellenberg-Karlsson, Lennat Åström, Lars Franzen

Eur Urol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel Versus Surveillance After Radical Radiotherapy for Intermediate- or High-risk Prostate Cancer-Results from the Prospective, Randomised, Open-label Phase III SPCG-13 Trial.
Pirkko-Liisa Kellokumpu-Lehtinen, Marie Hjälm-Eriksson, Camilla Thellenberg-Karlsson, Lennart Åström, Lars Franzen

Eur Urol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
Anders Widmark, Adalsteinn Gunnlaugsson, Lars Beckman, Camilla Thellenberg-Karlsson, Morten Hoyer

Lancet· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial.
Christopher C Parker, Robert E Coleman, Oliver Sartor, Nicholas J Vogelzang, David Bottomley

Eur Urol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in health related quality of life in the randomised ARTSCAN study; accelerated vs. conventional radiotherapy for head and neck cancer. A five year follow up.
Johanna Nyqvist, Per Fransson, Göran Laurell, Eva Hammerlid, Elisabeth Kjellén

Radiother Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mature results from a Swedish comparison study of conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN trial.
Björn Zackrisson, Elisabeth Kjellén, Karin Söderström, Eva Brun, Jan Nyman

Radiother Oncol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium-223 chloride in patients with castration-resistant prostate cancer and bone metastases.
Sten Nilsson, Lars Franzén, Christopher Parker, Christopher Tyrrell, René Blom

Clin Genitourin Cancer· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma--the ARTSCAN study.
Björn Zackrisson, Per Nilsson, Elisabeth Kjellén, Karl-Axel Johansson, Hans Modig

Radiother Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary malignancies from prostate cancer radiation treatment: a risk analysis of the influence of target margins and fractionation patterns.
Alexandru Daşu, Iuliana Toma-Daşu, Lars Franzén, Anders Widmark, Per Nilsson

Int J Radiat Oncol Biol Phys· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Roger Henriksson, Jacek Capala, Annika Michanek, Sten-Ake Lindahl, Leif G Salford

Radiother Oncol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of three instrumental methods for the objective evaluation of radiotherapy induced erythema in breast cancer patients and a study of the effect of skin lotions.
Josefina Nyström, Ann-Christine Svensk, Britta Lindholm-Sethson, Paul Geladi, Johan Larson

Acta Oncol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study.
Sten Nilsson, Lars Franzén, Christopher Parker, Christopher Tyrrell, René Blom

Lancet Oncol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REMOVED: Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase 2 study evaluating a prolonged high dose of boronophenylalanine (BPA).
Roger Henriksson, Jacek Capala, Britta H-Stenstam, Annika Michanek, Sten-Ke Lindahl

Radiother Oncol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Objective measurements of radiotherapy-induced erythema.
Josefina Nyström, Paul Geladi, Britta Lindholm-Sethson, Jenny Rattfelt, Ann-Christin Svensk, Lars Franzen

Skin Res Technol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Penis holder for external radiation treatment.
Per-Olov Löfroth, Per Bergström, Cenneth Forsmark, Nils-Olov Karlsson, Lars Franzén

Radiother Oncol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Joint Center--a collaboration project for optimal decentralized radiotherapy].
Anders Björeland, Michael Blomquist, Anders Sätherberg, Per Bergström, Mikael Karlsson

Lakartidningen· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daily-diary evaluated side effects of dose-escalation radiotherapy of prostate cancer using the stereotactic BeamCath technique.
Per Fransson, Per Bergström, Per-Olov Löfroth, Lars Franzén, Roger Henriksson

Acta Oncol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden.
Jacek Capala, Britta H Stenstam, Kurt Sköld, Per Munck af Rosenschöld, Valerio Giusti, Lars Franzen

J Neurooncol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis